Protalix BioTherapeutics, Inc PLX was a big mover last session, as the company saw its shares rise 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which …
To use net proceeds from this offering, together with current cash resources, to advance aspertec 325 mg to market-readiness * Pricing of registered direct offering of 2.65 million shares of common stock at an offering price per share of …
Reuters10mon
The article published is based on studies that examined the effect of PLX cells that had been induced with tumor ... The …
Protalix BioTherapeutics, Inc. PLX announced that the European Commission (“EC ... But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% …
HOUSTON (AP) _ PLx Pharma Inc. (PLXP) on Thursday reported a loss of $ ... using data from Zacks Investment Research. Access a Zacks stock report on PLXP at https://www.zacks.com/ap/PLXP
Yahoo!5mon